Actively Recruiting
Microangiopathy in Diabetes
Led by Karolinska Institutet · Updated on 2025-08-28
400
Participants Needed
1
Research Sites
195 weeks
Total Duration
On this page
Sponsors
K
Karolinska Institutet
Lead Sponsor
N
Neko Health AB
Collaborating Sponsor
AI-Summary
What this Trial Is About
This clinical trial aims to evaluate the use of a contactless and non-invasive technique to measure the properties of the skin's microcirculation and its regulatory functions in both healthy individuals and patients with microvascular disease associated with type 1 diabetes. It is hoped that the study results will lead to the development of a useful method for detecting diabetic complications at an early stage, thereby enabling treatment and preventive measures before the onset of severe microangiopathy.
CONDITIONS
Official Title
Microangiopathy in Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have type 1 diabetes mellitus.
- Meet cohort specific inclusion criteria as described in the study 'groups' section.
You will not qualify if you...
- Unable to understand patient information due to cognitive impairment.
- Unable to understand patient information due to language barriers.
- Have an ongoing acute infection or inflammatory condition.
- Are pregnant or breastfeeding.
- Have damaged or scarred tissue in the skin areas to be examined by the devices.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Danderyd University Hospital
Danderyd, Stockholm County, Sweden, 182 88
Actively Recruiting
Research Team
S
Sara Tehrani, Medical Doctor
CONTACT
J
Jacob Widaeus, Medical Doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here